Neurodiagnostics
Market Analysis By Regions (North America, Europe, Asia-Pacific, Latin
America and Africa), Product, Size, Share, Trends, Growth Factors, Revenue By
Application And Segment Forecasts To 2027.
Global Neurodiagnostics Market is
anticipated to reach at USD 18.3 billion by 2024. Neurodiagnostics are also
known as “Neurodiagnostic tests”. They diagnose neurological disorders such as
migraine, Parkinson’s disease, stroke, ischemic stroke and epilepsy. The
factors that propel the growth of the Neurodiagnostics Market include
increasing occurrence of neurological disorders such as stroke, growing
consciousness among people and technological developments. On the other hand,
there are factors that may hamper the growth of the market including lack of
mental health checkup & regular diagnosis in emerging countries. Neurodiagnostics
industry is anticipated to grow at a significant CAGR in the upcoming period as
the scope, product types, and its applications are increasing across the globe.
Get a Free Sample Copy of Report @ https://www.millioninsights.com/industry-reports/neurodiagnostics-market/request-sample
The market may be explored by
product type, end users, technology, and geography. The industry may be
explored by product type as intracranial pressure monitor, Electromyography
(EMG), Electroencephalogram (EEG), Transcranial Doppler, and Cerebral oximeters.
The “Electroencephalogram (EEG)” segment led the Neurodiagnostics Market in
2015 and is anticipated to maintain its dominance by 2024.The key factor that
could be attributed to the growth of market includes capacity to efficiently
diagnoze epilepsy and the other neurological disorders through non-invasive
methods.
Neurodiagnostics industry may be
explored by technology as neuroimaging technologies that may further include
Nuclear Medicine Imaging (SPECT, PET), Magnetic Resonance Imaging (MRI), Computed
Tomography (CT), Electroencephalography (EEG), Near Infrared Spectroscopic
Imaging (NIRS), Voxel-based Morphometry (VBM), and Magnetoencephalography (MEG)
in vitro diagnostics, and neuroinformatic.
The “CT and MRI” segment led the
neurodiagnostics industry in 2015 and is anticipated to maintain its dominance
by 2024.The factors that could be attributed to the growth of the segment might
include increasing adoption in the internal body surgeries. The market could be
explored based on end users as hospitals, operation theatres,
neurophysiological
laboratories and clinics.
North America accounted for the
major share of the Neurodiagnostics Market Size in 2015 and will continue to
lead in the forecast period. The factors that could be attributed to the growth
include increasing acceptance of neurodiagnostics technology.
Some of the key players that fuel
the growth of the neurodiagnostics industry comprise Alpha Omega Ltd., Bruker,
Guerbet, Agilent Technologies, Fonar Corporation, Doric Lenses, Inc., GE Healthcare,
Hitachi Medical Corporation, Hologic Inc., Mightex Systems, NeuroNexus
Technologies, Neusoft Medical Systems Co., Ltd., Roche Diagnostics, Plexon,
Inc., Philips Healthcare, Siemens Healthcare and Toshiba Medical Systems
Corporation. The leading companies are taking up partnerships, mergers and
acquisitions, and joint ventures in order to boost the inorganic growth of the
industry.
Avail complete report with TOC and List of Figures @ https://www.millioninsights.com/industry-reports/neurodiagnostics-market